Product
KN-002
1 clinical trial
1 indication
Indication
AsthmaClinical trial
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, PK, and PD of Single Ascending Doses of KN-002 in Healthy Subjects and Multiple Ascending Doses of KN-002 in Subjects With Mild Asthma, Moderate-Severe Asthma and COPDStatus: Active (not recruiting), Estimated PCD: 2023-12-20